PHILADELPHIA – The American Society of Clinical Oncology (ASCO) and ASCO's Conquer Cancer Foundation have announced that two of their top prizes will honor two members of the Abramson Cancer Center at the University of Pennsylvania at this year’s annual meeting. Lynn M. Schuchter, MD, chief of Hematology-Oncology, will receive the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award, and Lawrence N. Shulman, MD, FACP, deputy director for clinical services, will receive the Humanitarian Award. Both honorees will receive their awards during the ASCO Annual Meeting in Chicago starting May 31.
The Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award recognizes extraordinary female leaders and role models who have excelled as a mentor and who have demonstrated outstanding commitment to the professional development of female colleagues as clinicians, educators, and researchers in oncology. Schuchter is the C. Willard Robinson Professor of Hematology-Oncology and the program leader for the Melanoma and Cutaneous Malignancies Program. Her clinical research focuses on melanoma, with particular interest in novel therapies for advanced disease. She has a strong commitment to and passion for mentorship, especially for women. She has, by example and through her leadership, worked to promote and pave the way for women at Penn and for women and men in oncology.
Lawrence N. Shulman, MD, FACP
First presented in 2011, the Humanitarian Award recognizes an oncologist who personifies ASCO’s mission and values by going above and beyond the call of duty in providing outstanding patient care through innovative means or exceptional service or leadership in the United States or abroad. Shulman is a professor of Medicine and director of the Center for Global Cancer Medicine. A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies, and implementation of cancer treatment programs in low-resource settings. Shulman serves as senior oncology advisor to the nonprofit organization Partners In Health, where he plays a leadership role in the establishment of national cancer treatment programs with the Ministries of Health in Rwanda and Haiti. He sits on the Vice Chancellor’s Advisory Council for Rwanda’s University for Global Health Equity. He is involved in the development of the national oncology program in Botswana through the Botswana-UPenn Partnership.
For more information and a full list of the 2019 ASCO Awardees, visit ASCO’s website.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.